AURKA and cholangiocarcinoma: We hypothesized that this can be exploited therapeutically with AURKA inhibition, and we tested the antitumor activity of the selective AURKA inhibitor Alisertib in vitro in cholangiocarcinoma cell lines and in vivo in a mouse xenograft model.